IRVINE, CA--(Marketwire - October 21, 2008) - Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2008 of $32.9 million, or $0.56 per diluted share, compared to net income of $29.1 million, or $0.48 per diluted share, for the same period in 2007. Excluding the special gain detailed in the reconciliation table below, third quarter 2007 net income was $27.6 million, or $0.46 per diluted share.
